Preparation method and application of nanometer particles of taxane drugs

A taxane and nanoparticle technology, which is applied in the directions of drug combinations, pharmaceutical formulations, and inactive medical preparations, can solve the problems of long-circulating nanoparticles without a preparation process, immaturity and the like, and achieves low histamine levels. Release effect, low viscosity, low toxicity effect

Active Publication Date: 2013-08-28
HANGZHOU PUSH KANG BIOTECH CO LTD
View PDF3 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In general, the current technology for preparing long-circulating taxane nanoparticles is not yet mature, and there i...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method and application of nanometer particles of taxane drugs
  • Preparation method and application of nanometer particles of taxane drugs
  • Preparation method and application of nanometer particles of taxane drugs

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035] Implementation example 1: Preparation of TPGS emulsified paclitaxel nanoparticles

[0036] 80mg PLGA (50:50, molecular weight 45000) and 8mg paclitaxel were dissolved in 20mL acetone solvent as oil phase, 240mgTPGS was dissolved in 40mL water and ethanol volume ratio is 1: 1 in the cosolvent of 1 forming mixed solution; Drop into the mixed solution containing TPGS at a speed of 1 min, and form a light blue nanoemulsion under low-speed stirring at 300 r / min. After the addition is completed, transfer the nanoemulsion to a rotary evaporator to remove the organic solvent by vacuum rotation to obtain nanoparticles. The average particle size measured by the laser dynamic scattering instrument is 105.1±2.3nm, and the particle size distribution is as follows: figure 1 As shown, the particle size distribution coefficient PDI is 0.047±0.025, and the encapsulation efficiency of nanoparticles is 92.5±2.2%. The morphology of the prepared nanoparticles was analyzed by transmission...

Embodiment 2

[0037] Implementation example 2: Preparation of TPGS emulsified paclitaxel nanoparticles

[0038] 80mg PLGA (50:50, molecular weight 15000) and 8mg paclitaxel were dissolved in 20mL acetone solvent as oil phase, 240mgTPGS was dissolved in 40mL water and ethanol volume ratio is 1: 1 in the co-solvent of ethanol to form mixed solution; Drop into the mixed solution containing TPGS at a speed of 1 min, and form a light blue nanoemulsion under low-speed stirring at 300 r / min. After the addition is completed, transfer the nanoemulsion to a rotary evaporator to remove the organic solvent by vacuum rotation to obtain nanoparticles. The average particle size measured by the laser dynamic scattering instrument is 102.3±2.4nm, the particle size distribution coefficient PDI is 0.073±0.012, and the encapsulation efficiency of the nanoparticles is 85.2±2.4%.

Embodiment 3

[0039] Implementation example 3: Preparation of TPGS emulsified paclitaxel nanoparticles

[0040] 80mg PLGA (50:50, molecular weight 100000) and 8mg paclitaxel were dissolved in 20mL of acetone solvent as the oil phase, 240mgTPGS was dissolved in 40mL of water and ethanol with a volume ratio of 1:1 to form a mixed solution; the oil phase was dissolved in 1mL / Drop into the mixed solution containing TPGS at a speed of 1 min, and form a light blue nanoemulsion under low-speed stirring at 300 r / min. After the addition is completed, transfer the nanoemulsion to a rotary evaporator to remove the organic solvent by vacuum rotation to obtain nanoparticles. The average particle size measured by the laser dynamic scattering instrument is 109.1±2.2nm, the particle size distribution coefficient PDI is 0.062±0.018, and the encapsulation efficiency of the nanoparticles is 86.4±2.1%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
The average particle sizeaaaaaaaaaa
Login to view more

Abstract

The invention discloses a preparation method of a nanometer preparation of taxane drugs. The nanometer particles prepared by utilizing an emulsion diffusion method comprise the taxane drugs, copolymer carrier materials and emulgators. The preparation method comprises the steps of: dissolving the taxane drugs and the copolymer carrier materials into an organic phase mutually soluble with water, then dropwise adding the solution into a mixed solution of water in which the emulgators are dissolved and ethanol, stirring and mixing to form emulsion, and forming nanometer particles after removing organic solvents and solidifying. According to the nanometer particles prepared by utilizing the preparation method, the particle sizes are very uniform, the average particle size is 80-120 nm, the encapsulation efficiency is high, the stability is good, the preparation process is simple and controllable, and the scaled-up production is liable. The nanometer particles prepared by utilizing the preparation method can be applied to the treatment of malignant tumors and have obvious tumor inhibition effects.

Description

technical field [0001] The invention belongs to the field of pharmaceutical preparations, and relates to polymer nanoparticles loaded with insoluble antitumor drugs, in particular to a preparation method and application of nanoparticles containing taxane-type insoluble antitumor drugs. Background technique [0002] Taxane drugs mainly include paclitaxel and docetaxel, which are currently one of the most effective clinical antitumor drugs. Paclitaxel is a tetracyclic diterpenoid isolated from the bark of Pacific yew, with the molecular formula C 47 h 51 o 14 N, the molecular weight is 853.9, insoluble in water. Approved by the US FDA in 1992, its mechanism of action is to bind to cellular tubulin and promote tubulin polymerization to resist depolymerization and block mitosis, thereby inhibiting tumor growth and inducing tumor cell apoptosis. Clinical studies have confirmed that paclitaxel has a significant effect in the treatment of various solid tumors, including breast ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K47/34A61K31/337A61K9/14A61P35/00
Inventor 余波王国营张晓敏周晨光李剑光
Owner HANGZHOU PUSH KANG BIOTECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap